Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.21.2
Equity (Tables)
6 Months Ended
Jun. 30, 2021
Stockholders' Equity Note [Abstract]  
Schedule of stock options outstanding
Options Outstanding     Options Exercisable  
Range of
Exercise Price
    Number
Outstanding at
June 30,
2021
    Weighted Average Remaining
Contractual Life
(Years)
    Weighted
Average
Exercise Price
    Number
Exercisable at
June 30,
2021
    Weighted
Average
Exercise Price
 
$ 0.50       2,000,000       5.61     $ 0.50       2,000,000     $ 0.50  
  1.00 – 1.93       2,930,000       5.12       1.39       2,510,000       1.44  
  2.00 – 2.80       2,740,000       2.27       2.17       2,740,000       2.17  
  4.76       30,000       2.76       4.76       30,000       4.76  
$ 0.50 – 4.76       7,700,000       4.22     $ 1.45       7,280,000     $ 1.47  

 

Schedule of stock option activities
    Number of Options     Weighted Average Exercise Price  
Outstanding at January 1, 2021     7,140,000     $ 1.48  
Granted     640,000       1.10  
Terminated / Exercised / Expired     (80,000 )     (1.00 )
Outstanding at June 30, 2021     7,700,000     $ 1.45  
Options exercisable at June 30, 2021     7,280,000     $ 1.47  
Options expected to vest     420,000     $ 1.08  

 

Schedule of fair value of the options using the Black-Scholes option-pricing model
    Number of Options     Weighted Average Exercise Price  
Nonvested at January 1, 2021     218,334     $ 1.18  
Granted     640,000       1.10  
Vested     (438,334 )     (1.15 )
Nonvested at June 30, 2021     420,000     $ 1.08